Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Malaria Research in NIAID Labs

Laboratory of Malaria and Vector Research (LMVR)

About LMVR

LMVR is dedicated to studies of malaria and insect vectors of infectious diseases. Research groups in the laboratory maintain an array of on-campus and overseas activities investigating disease-transmitting insects and broad areas of malaria biology and pathogenesis. Basic discoveries from these investigations support searches for new drug treatments, diagnostic tools, and vaccines.

Malaria Drug Resistance and Disease Severity

LMVR supports a spectrum of clinical and laboratory research projects on malaria and the mosquitoes responsible for its transmission.

Laboratory of Malaria Immunology and Vaccinology (LMIV)

About LMIV

LIMV was commissioned in 2001 to research, develop, and produce prototype malaria vaccines and conduct early-phase clinical trials of promising vaccine candidates. Its overarching goal is to develop malaria vaccines that will reduce severe disease and death among African children and eliminate malaria from low-transmission areas of the world.

Scientists Pursue Vaccine Against Severe Malaria

LMIV is developing a vaccine that targets the “blood stage” of the deadliest malaria-causing parasite, Plasmodium falciparum. A blood-stage vaccine elicits immune responses capable of either destroying malaria parasites in the bloodstream or inhibiting parasites from infecting red blood cells.

Featured Research

back to top

Last Updated November 08, 2009